Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending September 30, 2022 was -16.07% (a -109.24% decrease compared to previous quarter)
- Annual Research and Development (R&D) Expenses Growth for 2021 was -13.12% (a -291.53% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 6.85% (a -206.86% decrease from previous year)
Visit stockrow.com/BBLN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Babylon Holdings Limited
Most recent Research and Development (R&D) Expenses Growthof BBLN including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Babylon Holdings Limited
Babylon Holdings Limited Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -16.07% | 173.94% | -3.21% | – |
| 2021 | – | – | – | – | -13.12% |
| 2020 | – | – | – | – | 6.85% |
| 2019 | – | – | – | – | -6.41% |
Business Profile of Babylon Holdings Limited
Sector: Healthcare
Industry: Health Information Services